2 August 2023
RegMedNet: Standardizing Cell Therapy Processes
In this interview, Josh Ludwig talks about the importance of collaboration and standardization in developing and manufacturing cell therapies. Josh explains...
25 July 2023
The Medicine Maker: Roundtable Discussion — Redefining Manufacturing
Watch the roundtable discussion from Medicine Maker featuring experts from ScaleReady, Terumo Blood and Cell Technologies, Orgenesis, and BioBridge Global.
21 July 2023
Pharma's Almanac: Artificial Intelligence (AI) Trends in Biopharma
Pharma's Almanac
In this edition of Pharma's Almanac, industry experts, including Josh Ludwig, Global Director of ScaleReady, discuss increased innovation and adoption of artificial intelligence (AI) and machine learning in biopharma.
28 June 2023
ISCT 2023: Highlighting Key Trends Redefining Manufacturing in the Biotech Industry
The International Society for Cell & GeneTherapy (ISCT) recently hosted its annual conference, ISCT 2023, which shed light on several key trends that are currently redefining the landscape of manufacturing in this rapidly evolving field.
21 June 2023
ISCT 2023 Paris: In Conversation with Josh Ludwig, Global Commercial Director, ScaleReady
In this interview, Josh Ludwig, Global Director of Commercial Operations at ScaleReady, describes key industry themes discussed during ISCT 2023.
8 June 2023
Cell & Gene Therapy Insights: D More with Less Cell Culture in Immune Cell Therapies
In this expert roundtable, David McCall, Senior Editor, BioInsights, speaks to Anastasiya Smith, Senior Director of R&D, CellReady; Josh Ludwig, Global Director, Commercial Operations, ScaleReady; and David Hermanson, Senior Manager of R&D Applications, Cell and Gene Therapy, Bio-Techne.
13 April 2023
BioCentury: Cell and gene therapy must prioritize simplification, standardization before focusing on automation
Josh Ludwig, Global Director of Commercial Operations at ScaleReady, reviews how the industry is addressing the challenges that come with...
2 March 2023
Phacilitate: Early Adoption and Partnerships – The Secret to Commercialization Success?
Terumo’s Stuart Gibb, Ph.D., at Terumo Blood and Cell Technologies, is joined by Nisha C. Durand, PhD, at Mayo Clinic and Matthew M. Hewitt, B.A. Ph.D., Charles River.
9 February 2023
For the Record - Medical Alley Interview with Josh Ludwig
Medical Alley
Catch up with the editors from Medical Alley as they interview ScaleReady Global Commercial Director, Josh Ludwig for their regular...
7 October 2021
CancerNetworks Interviews ScaleReady
Josh Ludgwig, Global Director of Commercial Operations at ScaleReady discusses what makes the company uniquely positioned to support manufacturing across...
1 October 2021
ScaleReady Joins the Alliance for Regenerative Medicine
As a member of The Alliance for Regenerative Medicine (ARM), ScaleReady committed to progressing regenerative medicine and advanced therapy manufacturing...
25 May 2021
RegMedNet interviews Josh Ludwig, Global Commercial Director
In this interview, Josh Ludwig, Global Director of Commercial Operations at ScaleReady, describes how a scalable, cost-effective and practical manufacturing...